Cilostazol, a selective type III phosphodiesterase inhibitor, decreases triglyceride and increases HDL cholesterol levels by increasing lipoprotein lipase activity in rats

✍ Scribed by Takeshi Tani; Kenji Uehara; Toshiki Sudo; Keiko Marukawa; Yoshinobu Yasuda; Yukio Kimura

• Book ID: 119438772
• Publisher: Elsevier Science
• Year: 2000
• Tongue: English
• Weight: 145 KB
• Volume: 152
• Category: Article
• ISSN: 0021-9150
• DOI: 10.1016/s0021-9150(99)00480-3